Skip to main content

Research Repository

Advanced Search

Collagenase Injection versus Limited Fasciectomy for Dupuytren’s Contracture

Dias, Joseph; Tharmanathan, Puvanendran; Arundel, Catherine; Welch, Charlie; Math, M.; Wu, Qi; Leighton, Paul; Armaou, Maria; Johnson, Nick; James, Sophie; Cooke, John; Bainbridge, Lionel; Craigen, Michael; Warwick, David; Brady, Samantha; Flett, Lydia G.; Jones, Judy; Knowlson, Catherine N.; Watson, Michelle; Keding, Ada; Hewitt, Catherine E.; Torgerson, David

Authors

Joseph Dias

Puvanendran Tharmanathan

Catherine Arundel

Charlie Welch

M. Math

Qi Wu

Dr PAUL LEIGHTON PAUL.LEIGHTON@NOTTINGHAM.AC.UK
ASSOCIATE PROFESSOR OF APPLIED HEALTH SERVICES RESEARCH

Maria Armaou

Nick Johnson

Sophie James

John Cooke

Lionel Bainbridge

Michael Craigen

David Warwick

Samantha Brady

Lydia G. Flett

Judy Jones

Catherine N. Knowlson

Michelle Watson

Ada Keding

Catherine E. Hewitt

David Torgerson



Abstract

Background
Treatments for Dupuytren’s contracture include limited fasciectomy and collagenase injection. Comparisons of the effectiveness of these treatments have been limited.

Methods
We performed an unblinded, multicenter, pragmatic, two-group, randomized, controlled noninferiority trial comparing collagenase injection with limited fasciectomy in persons with moderate Dupuytren’s contracture. The primary outcome was the score on the Patient Evaluation Measure–Hand Health Profile (PEM), a questionnaire for assessing hand health as reported by the patient, at 1 year after treatment. Scores on the PEM range from 0 to 100, with higher scores indicating worse outcomes. The prespecified noninferiority margin was 6 points.

Results
A total of 672 persons (336 per group) were assigned to receive collagenase injection or to undergo limited fasciectomy. The primary analysis included 599 persons: 314 in the collagenase group and 285 in the limited-fasciectomy group. The mean score on the PEM at 1 year was 17.8 among the 284 patients with available data in the collagenase group and 11.9 among the 250 patients with available data in the limited-fasciectomy group (estimated difference, 5.9 points; 95% confidence interval [CI], 3.1 to 8.8; one-sided P=0.49 for noninferiority). Among the patients with available data (229 patients in the collagenase group and 197 patients in the limited-fasciectomy group), the estimated difference in the mean score on the PEM at 2 years was 7.2 points (95% CI, 4.2 to 10.9). Moderate or severe complications of treatment occurred in 1.8% of the patients in the collagenase group and in 5.1% of those in the limited-fasciectomy group; recurrent contracture resulted in reintervention in 14.6% and 3.4%, respectively.

Conclusions
Collagenase injection was not noninferior to limited fasciectomy with respect to the score on the PEM at 1 year after treatment.

Citation

Dias, J., Tharmanathan, P., Arundel, C., Welch, C., Math, M., Wu, Q., Leighton, P., Armaou, M., Johnson, N., James, S., Cooke, J., Bainbridge, L., Craigen, M., Warwick, D., Brady, S., Flett, L. G., Jones, J., Knowlson, C. N., Watson, M., Keding, A., …Torgerson, D. (2024). Collagenase Injection versus Limited Fasciectomy for Dupuytren’s Contracture. New England Journal of Medicine, 391(16), 1499-1510. https://doi.org/10.1056/NEJMoa2312631

Journal Article Type Article
Acceptance Date Jun 22, 2024
Online Publication Date Oct 9, 2024
Publication Date Oct 24, 2024
Deposit Date Aug 9, 2024
Publicly Available Date Apr 10, 2025
Journal New England Journal of Medicine
Print ISSN 0028-4793
Electronic ISSN 1533-4406
Publisher Massachusetts Medical Society
Peer Reviewed Peer Reviewed
Volume 391
Issue 16
Pages 1499-1510
DOI https://doi.org/10.1056/NEJMoa2312631
Public URL https://nottingham-repository.worktribe.com/output/29262803
Publisher URL https://www.nejm.org/doi/full/10.1056/NEJMoa2312631